Norovirus Gastroenteritis
📧 Sign up to get email alerts when something new happens for Norovirus Gastroenteritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis [Phase 3]
A Phase 3 study evaluating the safety and efficacy of mRNA-1403 in adults to prevent acute gastroenteritis, including norovirus-associated c…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) [Phase 3]
A Phase 3 trial is evaluating the protective efficacy of a quadrivalent recombinant norovirus vaccine produced in Pichia pastoris for acute …
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Phase I Norovirus Challenge Model [Phase 1]
Phase I Norovirus challenge model study completed, with results posted in 2024. The study aims to model Norovirus infection and characterize…
-
CLINICAL_TRIALS withdrawal · 2024-08-23Clinical Trial Update: Validation of a Boindicator as Monitoring Tool for Oyster Norovirus Outbreak [NA]
A withdrawn clinical trial (NCT06568380) evaluating a Boindicator as a monitoring tool for oyster-associated Norovirus outbreaks. Sponsor: C…
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: NNITS-Nitazoxanide for Norovirus in Transplant Patients Study [Phase 2]
Phase 2 trial results for NNITS-Nitazoxanide in norovirus gastroenteritis among transplant patients have been completed and posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine [Phase 1]
Phase 1, placebo-controlled randomized trial evaluating an adenoviral-vector Norovirus vaccine by Vaxart has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers [Phase 1]
Reports Phase 1 dose-optimization results for the VXA-G1.1-NN candidate in healthy volunteers.
-
CLINICAL_TRIALS withdrawal · 2016-06-03Clinical Trial Update: Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1) [Phase 1]
Phase I study to determine the optimal human challenge dose for a Norovirus GII.4 challenge stock has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: New Challenge Pool of Norwalk Virus Inoculum [Phase 1]
The document notes the completion of a Phase 1 study evaluating a new Norwalk virus (Norovirus) inoculum for gastroenteritis challenge studi…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Infectivity of Norovirus in Groundwater-Human Challenge Study [NA]
This clinical trial update notes the completion of a human challenge study by Emory University investigating norovirus infectivity in ground…